| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 39.6535 | 6 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.8845 | 36 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.0817 | 27 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.4305 | 29 |
| GSM780720 | Untreated after 4 days (C2_2) | 37.0353 | 2 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.4053 | 24 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.4695 | 34 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.7896 | 21 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.5047 | 34 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.6896 | 26 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 41.9006 | 13 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 41.2985 | 10 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 49.2326 | 46 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.1053 | 33 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.7792 | 26 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.5782 | 35 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.5961 | 25 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 39.6448 | 6 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.7963 | 21 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.656 | 30 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.1 | 42 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.8428 | 26 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 39.857 | 6 |